Re-irradiation for children with recurrent medulloblastoma in Toronto, Canada: a 20-year experience.

Derek S TsangNasim SarhanVijay RamsawamiLiana NobreRyan YeeMichael D TaylorCynthia HawkinsUte BartelsAnnie HuangUri TaboriDavid C HodgsonEric BouffetNormand Laperriere

Published in: Journal of neuro-oncology (2019)

Re-irradiation for recurrent pediatric medulloblastoma can offer some patients disease control, particularly those with focally recurrent disease in the brain. Prospective studies are needed to confirm subgroups of patients who may benefit most from RT2.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
young adults
prognostic factors
peritoneal dialysis
white matter
patient reported outcomes
brain injury
blood brain barrier